127 related articles for article (PubMed ID: 29254180)
1. NOD2 maybe a biomarker for the survival of kidney cancer patients.
Xu D; Zhang S; Zhang S; Liu H; Li P; Yu L; Shang H; Hou Y; Tian Y
Oncotarget; 2017 Nov; 8(60):101489-101499. PubMed ID: 29254180
[TBL] [Abstract][Full Text] [Related]
2. Hyper expression of MTBP may be an adverse signal for the survival of some malignant tumors: A data-based analysis and clinical observation.
Mao Y; Tian M; Pan B; Zhu Q; Li P; Liu H; Liu W; Dai N; Yu L; Tian Y
Medicine (Baltimore); 2018 Aug; 97(35):e12021. PubMed ID: 30170409
[TBL] [Abstract][Full Text] [Related]
3. OSkirc: a web tool for identifying prognostic biomarkers in kidney renal clear cell carcinoma.
Xie L; Wang Q; Dang Y; Ge L; Sun X; Li N; Han Y; Yan Z; Zhang L; Li Y; Zhang H; Guo X
Future Oncol; 2019 Sep; 15(27):3103-3110. PubMed ID: 31368353
[No Abstract] [Full Text] [Related]
4. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
Front Genet; 2020; 11():568192. PubMed ID: 33133154
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
6. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
7. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
8. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a 12-gene expression signature to predict colon cancer prognosis.
Sun D; Chen J; Liu L; Zhao G; Dong P; Wu B; Wang J; Dong L
PeerJ; 2018; 6():e4942. PubMed ID: 29915691
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors.
Mayor NP; Shaw BE; Hughes DA; Maldonado-Torres H; Madrigal JA; Keshav S; Marsh SG
J Clin Oncol; 2007 Sep; 25(27):4262-9. PubMed ID: 17724347
[TBL] [Abstract][Full Text] [Related]
11. Autophagy-related gene
Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
13. New insights into genetic characteristics between multiple myeloma and COVID-19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data.
Wang F; Liu R; Yang J; Chen B
Int J Lab Hematol; 2021 Dec; 43(6):1325-1333. PubMed ID: 34623759
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
[TBL] [Abstract][Full Text] [Related]
15. NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma.
Wang X; Yang C; Liao X; Han C; Yu T; Huang K; Yu L; Qin W; Zhu G; Su H; Liu X; Ye X; Chen B; Peng M; Peng T
Cancer Med; 2017 Nov; 6(11):2660-2672. PubMed ID: 28960882
[TBL] [Abstract][Full Text] [Related]
16. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
17. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma.
Ren X; Ma L; Wang N; Zhou R; Wu J; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Zhou Z
Front Genet; 2021; 12():721252. PubMed ID: 34490047
[No Abstract] [Full Text] [Related]
19. RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Li D; Tang L; Liu B; Xu S; Jin M; Bo W
Aging (Albany NY); 2021 Mar; 13(7):10450-10467. PubMed ID: 33790054
[No Abstract] [Full Text] [Related]
20. Predictive values of Notch signalling in renal carcinoma.
Jędroszka D; Orzechowska M; Bednarek AK
Arch Med Sci; 2017 Oct; 13(6):1249-1254. PubMed ID: 29181054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]